Permezel M
Department of Obstetrics and Gynaecology, University of Melbourne, Royal Women's Hospital, Carlton.
Aust N Z J Obstet Gynaecol. 1990 Feb;30(1):77-80. doi: 10.1111/j.1479-828x.1990.tb03203.x.
RU 486 (Mifepristone) represents a major development in the field of hormone antagonists as the first effective antiprogestogen. A number of therapeutic roles for the drug are envisaged. It is already being used extensively around the world for the procurement of first trimester abortion--particularly in combination with prostaglandins. It also has been shown to be effective as a cervical ripening agent and for the induction of labour. Initial human studies have involved nonviable pregnancies and more work is needed in animal models before the drug can be deemed safe for use in viable human pregnancies in the third trimester.
RU 486(米非司酮)作为首个有效的抗孕激素,是激素拮抗剂领域的一项重大进展。人们设想了该药物的多种治疗用途。它已在全球广泛用于早期妊娠流产——尤其是与前列腺素联合使用时。它还被证明是一种有效的宫颈成熟剂和引产药物。最初的人体研究涉及不可行的妊娠,在该药物被认为可安全用于晚期可行的人类妊娠之前,还需要在动物模型中开展更多研究。